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Abstract
Purpose Diagnosis from lung biopsy or autopsy was
performed in 445 patients with congenital (385) or
acquired (60) heart disease from all over Japan. The pur-
pose of this study is the presentation of these prospective
data collections.
Methods Of the patients with congenital heart disease,
354 were biopsied to determine whether surgery was
indicated. Decisions regarding surgery were based on the
index of pulmonary vascular disease in simple cardiac
anomalies or atrioventricular septal defects (AVSD). In
total anomalous pulmonary venous connection (TAPVC),
operative indication was determined by the degree of
hypoplasia of small pulmonary arteries. Operability of
Fontan procedure was based on the degree of residual
medial hypertrophy after pulmonary artery banding.
Results In patients with simple cardiac anomalies, radical
surgery was indicated in 166. Radical surgery was indicated
in 50 patients with AVSD. In 26 patients with TAPVC,
radical surgery was not indicated in 10. In 68 Fontan can-
didates, surgery was not indicated in 49. Among 7 patients
with tetralogy of Fallot, 1 was not a surgical candidate. Of
the 60 acquired heart disease patients, 16 had idiopathic
pulmonary arterial hypertension and 36 had chronic throm-
boembolic pulmonary hypertension. In 6 patients, lung
biopsy revealed pulmonary veno-occlusive disease; 2
patients had combined valvular disease.
Conclusion The cardiac surgeon, pediatric cardiologist,
and cardiologist who requested diagnosis from lung biopsy
or autopsy were gratified with the results.
Keywords Pulmonary vascular disease  Pulmonary
hypertension  Lung biopsy  Congenital heart disease 
Chronic thromboembolic pulmonary hypertension
Introduction
I performed either lung biopsy or autopsy diagnosis in a
total of 445 patients with pulmonary hypertension during
the 5-year period from 2007 to 2011, as requested by the
department of pediatric cardiology or cardiac surgery or
cardiovascular medicine from all over Japan. The purpose
of lung biopsy was to conclusively determine whether
surgery or other treatment modalities were indicated. The
purpose of autopsy was to conclusively determine in detail
the exact cause of death in patients with pulmonary
hypertension. Based on the pathological findings of pul-
monary vascular disease, lung biopsies were assessed
according to the diagnostic criteria for each disease; the
diagnostic results are described in this study.
Patients and methods
The 445 cases consisted of 385 cases of congenital heart
disease and 60 cases of acquired heart disease. The
breakdown is summarized in Tables 1 and 2.
Congenital heart disease
Of the 385 cases of congenital heart disease, 354 were lung
biopsy cases to determine whether surgery was indicated,
which excluded the following 3 diseases: 13 cases of total
anomalous pulmonary venous connection (TAPVC),
10 cases of complex cardiac anomalies, and 8 cases of
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idiopathic persistent pulmonary hypertension of the new-
born (IPPHN). Indication for lung biopsy in ventricular
septal defect (VSD) and/or patent ductus arteriosus (PDA)
and atrioventricular septal defect (AVSD) was determined
based on the previously reported hemodynamic criteria. [1]
In general, we evaluated whether surgery was indicated
according to the index of pulmonary vascular disease
(IPVD) [2] and the Heath–Edwards (HE) classification. [3]
To obtain the IPVD score, the severity of each occlusive
pulmonary vascular lesion in the small pulmonary arteries
was categorized as grade 1–4 and an arithmetic average for
all lesions was calculated in each case. The indication for
surgery differed slightly by primary disease. Whether sur-
gery was indicated for simple atrial septal defects (ASD)
was evaluated according to the previously reported criteria
[4], because systemic arterial pressure is not directly
applied to the pulmonary arteries, unlike in other simple
cardiac anomalies such as VSD or PDA. For simple cardiac
anomalies not associated with simple ASD, surgery was
indicated for IPVD B 2.0 in patients without Down syn-
drome and B2.1 in patients with Down syndrome [5].
Surgery was indicated for patients with AVSD with
IPVD B 2.0 [6]. Patients with absolute operative contra-
indication [7] were not considered candidates for surgery.
When an extremely thickened media was observed in
C10 % of all small pulmonary arteries, surgery was not
indicated [8]. For simple ASD, whether surgery was indi-
cated depended on the presence or absence of 4 patho-
logical conditions [4]. In particular, patients with ASD
associated with the following were considered candidates
for surgery: IPVD B 2.2 for the plexogenic arteriopathy
type, musculoelastosis [9], pulmonary thrombosis, or the
mixed type where no collateral circulation (e.g. plexiform
lesions) was observed. When wall thickness was greater
than 40 %, we considered the case to be associated with
idiopathic pulmonary arterial hypertension (IPAH).
In cases of lung biopsy, we categorized the lung biopsy
results into 1 of the following 5 categories by compre-
hensively taking into account the pathological findings
along with the status of the respiratory system and pul-
monary veins.
A. Absolutely no postoperative problems.
B. No operative or in-hospital death, but pulmonary
hypertension remains.
C. No operative or in-hospital death, but late death is
possible.
D. No operative or in-hospital death, but late death is
likely.
E. Operative or in-hospital death.
In cases of TAPVC, where hypoplasia of the small
pulmonary arteries significantly affects the prognosis [10],
categorization was performed based on the diameter of the
small pulmonary arteries parallel to the adjacent terminal
bronchi: A, diameter C80 % of normal; B, 60–80 %; C,
40–60 %; D, 20–40 %; and E, B 20 %. Of note, we rarely
found obstructive pulmonary vascular lesions.
The Fontan procedure was considered to be indicated if
the following were present: (1) complete normalization of
the hypertrophy of the media in all of the intraacinar small
pulmonary arteries and (2) complete normalization of the
hypertrophy of the media in C50 % of the preacinar small
pulmonary arteries after pulmonary artery banding (PAB)
[11]. Each case was categorized as A, B, or C depending on
the degree of pulmonary arterial normalization. Moreover,
patients with normalization of the hypertrophy of the media
in all the intraacinar small pulmonary arteries but B50 %
of the preacinar small pulmonary arteries were categorized
as D. Finally, cases where hypertrophy of the media in both
the preacinar and intraacinar small pulmonary arteries
remained were categorized as E.






1 year 11 months 164 0 164
Atrioventricular
septal defect
1 year 1 month 62 0 62
Simple ASD 9 years 11 months 27 0 27
TAPVC 2 months 26 13 39
Fontan candidate 7 years 68 0 68
Other CCA 1 year 1 month 0 10 10
Tetralogy of
Fallot
7 years 7 0 7
IPPHN 3 months 10 days 4 4 8
Total 358 27 385
VSD ventricular septal defect, PDA patent ductus arteriosus, ASD
atrial septal defect, TAPVC total anomalous pulmonary venous con-
nection, CCA complicated cardiac anomalies, IPPHN idiopathic
persistent pulmonary hypertension of the newborn




IPAH 20 years 13 3 16






53 years 2 0 2
Total 56 4 60
IPAH idiopathic arterial pulmonary hypertension, CTEPH chronic
thromboembolic pulmonary hypertension, PVOD pulmonary veno-
occlusive disease
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Acquired heart disease
For acquired heart disease, we diagnosed a total of 16 cases
of idiopathic pulmonary arterial hypertension (IPAH)
including 9 cases where lung tissue was collected during
lung transplantation, 4 cases associated with ASD in which
operability was asked, and 3 autopsy cases. IPAH cases
were categorized as either the juvenile type, where
hypertrophy of the media advanced in the early stage, or
the adult type where the pulmonary vascular obstructive
episode advanced in early stage [12]. The juvenile type was
mainly treated with pulmonary vasodilators. Lung biopsy
for chronic thromboembolic pulmonary hypertension
(CTEPH) was performed to evaluate the perioperative and
long-term postoperative prognosis. Valvular heart disease
patients were all considered to be candidates for surgery in
the absence of pulmonary veno-occlusive disease (PVOD).
Preparation of pathological specimens was performed as
follows: 30 pieces of step sections (with a 50 lm step)
were prepared to facilitate the pathological diagnosis.
Goldner’s trichrome stain combined with Weiger’s stain
for elastic fibers was performed [1, 2, 4–14].
Results
Congenital heart disease
The breakdown of the 385 congenital heart disease cases
was as follows: 164 cases of simple cardiac anomalies
excluding simple ASD (including 94 cases of Down syn-
drome); 62 AVSD (including 56 Down syndrome); 27
ASD (including 6 Down syndrome); 39 TAPVC (including
13 autopsy cases); 68 cases of complex cardiac anomalies
(Fontan candidates); 7 tetralogy of Fallot (TOF) associated
with pulmonary hypertension and 8 IPPHN (including 4
autopsy cases); and 10 autopsy cases of complex cardiac
anomalies.
Simple cardiac anomalies (VSD and/or PDA and/or ASD)
Lung biopsy was performed in all 164 cases of simple
cardiac anomalies. Patients ranged in age from 1 month to
58 years (mean, 23 months). Lung biopsy specimens were
collected preoperatively in 54 patients, during pulmonary
artery banding (PAB) in 96 patients, intraoperatively in 13
patients, and during PDA ligation in 1 patient.
Pathological examination revealed that radical surgery
was indicated in 145 patients (A, 62; B, 65; C, 18), but not
indicated in 19 patients (D, 9; E, 10). Patients evaluated as
D included 3 with an extremely thickened media in the
small pulmonary arteries (4, 5, and 7 months old). When
the 4-month-old patient underwent lung biopsy again at the
age of 18 months after PAB, the extremely thickened
media of the small pulmonary arteries reduced, and the
patient’s status improved to A. Hypoplasia of the small
pulmonary arteries was identified in 3 patients with Down
syndrome (2, 4, and 4 months old) and they were evaluated
as D. In a 34-month-old patient, smooth muscle cells were
completely absent, leading to a diagnosis of hypoplasia of
the small pulmonary arteries and evaluation as D. Hypo-
plasia of the respiratory system was also observed in 1
Down syndrome patient (4 months old) evaluated as D. In
addition, an impending absolute operative contraindication
was found in a 29-year-old evaluated as D. There were 9
patients evaluated as E, including 4 patients with Down
syndrome (1, 3, 6, and 11 months old) and 5 without Down
syndrome (1, 3, 4, 6, and 7 months old). Of these 5 patients
with absolute operative contraindication, in the 4-month-
old, a part of complete obstructive pulmonary vascular
lesions disappeared 1 year after PAB; likewise in the
7-month-old patient, similar changes were observed
2 years after PAB. Both ultimately underwent radical
surgery. In addition, 1 patient with extremely thickened
media of small pulmonary arteries was evaluated as E.
Of the 164 cases in which lung biopsy was performed,
94 were associated with Down syndrome (A, 38; B, 41; C,
6; D, 4; E, 5). No significant differences were found
between Down syndrome and non-Down syndrome
patients. The severity of the obstructive pulmonary vas-
cular lesions was assessed according to the HE classifica-
tion (I, 78; II, 48; III, 36; IV, 2). IPVD ranged from 1.0 to
3.0 (mean, 1.2). There were 3 patients with IPVD of 2.2,
2.9, and 3.0, exceeding the criteria for surgery.
AVSD
There were 62 patients with AVSD, whose ages ranged
from 14 days to 10 years (mean, 13 months). Of these 62
patients, 56 were associated with Down syndrome. Lung
biopsy specimens were collected during PAB intraopera-
tively, and preoperatively in 44, 4, and 3 patients, respec-
tively. The remaining 11 patients had previously undergone
PAB.
Radical surgery was indicated in 50 patients (A, 18; B,
27; C, 5) but not in 12 patients (D, 8; E, 4). The latter 12
cases were all associated with Down syndrome. The 8
cases evaluated as D were as follows: 4 patients had an
extremely thickened media in the small pulmonary arteries
(1, 6, 7, and 12 months old), 2 patients had impending
absolute contraindications to surgery (3 and 6 months old),
and 2 patients had IPVD C 2.1 (IPVD 2.1 in a 6-month-old
and 2.5 in an 8-year-old, respectively). Among the 4
patients evaluated as E, 3 had absolute operative contra-
indication (3, 4, and 42 months old) and 1 had extremely
thickened media of small pulmonary arteries (1 month old).
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The HE grade was I in 38 patients, II in 15, III in 9, and
IV in 0. IPVD ranged from 1.0 to 2.5 (mean, 1.2).
ASD
There were 27 patients with ASD whose ages ranged from
2 months to 45 years (mean, 9 years 11 months); 6 patients
had Down syndrome.
The breakdown of ASD was as follows: 16 patients with
plexogenic arteriopathy, 7 with IPAH, 3 with musculo-
elastosis, and 1 with an extremely thickened media in the
small pulmonary arteries. There were no cases associated
with pulmonary thrombosis.
Radical surgery was indicated in 21 patients (A, 2; B, 8;
C, 11), but not in 6 patients (D, 3; E, 3). Of the 3 patients
evaluated as D, 2 had IPAH (9 months, 22 years old) and 1
had advanced plexogenic arteriopathy with an IPVD of 2.8.
The 3 patients evaluated as E included 1 patient with ASD
associated with juvenile IPAH (21 years old), 1 with an
extremely thickened media in the small pulmonary arteries
(8 months old), and 1 with Eisenmenger syndrome (22 years
old). The patient with Eisenmenger syndrome had advanced
plexogenic arteriopathy (IPVD, 3.1) and many plexiform
lesions were observed as collateral circulation.
The HE grade was I in 10 patients, II in 5, III in 8, and
IV in 4. IPVD ranged from 1.0 to 3.1 (mean, 1.3).
TAPVC
Of these 39 patients with TAPVC, initial radical surgery
was performed in 20 patients (0 days to 3 months old;
mean, 10.5 days). To remove the pulmonary venous
obstruction (PVO), a second surgery was performed in 6
patients (3–6 months old; mean, 3.7 months). Autopsy was
performed in 13 cases (17 days to 22 months old; mean,
5.2 months). Lymphangiectasia was observed in 16 cases
(41 %).
The 20 patients who had radical surgery were rated as
follows A, 0; B, 5; C, 8; D, 6; and E; 1. The 6 patients who
had a second surgery were evaluated as follows: B, 1; C, 2;
and D, 3. The 13 autopsy cases included 6 cases of D and 7
cases of E. Of these 13 autopsy cases, the cause of death
was PVO in 12 cases and an extremely thickened media in
the small pulmonary arteries in 1 case. Severe hypoplasia
of the small pulmonary arteries was observed in 6 cases.
There was 1 case where the media in the small pulmonary
arteries was completely absent. The HE grade in patients
with initial radical surgery was I in 16 patients, II in 1, III
in 1, and IV in 2 (angiitis) and IPVD was 1.0 in 16 patients,
1.1 in 1, 1.2 in 2, and 1.6 in 1. In the 6 cases where lung
biopsy was performed during the second surgery to remove
the PVO, the HE grade was I in 3 patients, II in 2, and III in
1, and IPVD was 1.0 in 3 patients, 1.1 in 2, and 1.6 in 1. In
the 13 autopsy cases, the HE grade was I in 12 cases and III
in 1 (longitudinal smooth muscle bundle). IPVD was 1.0 in
11 cases and 1.1 in 1. IPVD was not evaluable in the case
with longitudinal smooth muscle bundles.
Complex cardiac malformations in Fontan candidates
The primary disease in Fontan candidates was as follows:
21 cases of single ventricle (SV) (0 days to 26 years; mean,
4.4 years), 14 of double outlet right ventricle (DORV)
(1 day to 16 years; mean, 4.2 years), 9 of hypoplastic left
heart syndrome (HLHS) (0 days to 8.7 years; mean,
1.6 months), 7 of AVSD (1 month to 7 years; mean,
2 years), 5 of tricuspid atresia (TA) (1 year to 28 years;
mean 5.2 years), 4 of transposition of the great arteries
(TGA) (1 month to 16 years; mean, 6.6 years), and 8 other
cases. In these 68 Fontan candidates, PAB was performed
in 57 patients, but not in 11 patients with preexisting pul-
monary stenosis (PS). The HE grade was 0 (no hypertrophy
of the media of the small pulmonary arteries) in 10
patients, I (only hypertrophy of the media was identified) in
34, II in 5, III in 10, and IV in 2. The HE grade could not be
determined in 7 cases due to thrombi. IPVD ranged from
1.0 to 2.8 (mean, 1.2) in 61 cases, excluding 7 cases where
thrombi were present.
Lung biopsy specimens were collected in 11 patients
during PAB, 47 during the Glenn procedure, 6 during re-
PAB, 3 of open lung biopsy performed after the Glenn
procedure, and 1 during the Fontan procedure. In the 11
patients whose lung biopsy specimens were collected
during PAB, age ranged from 0 days to 6 months (mean,
1.6 months). Since these 11 patients had hypertrophy of the
media, there was no A, B, or C ratings. Lung biopsy
resulted in 5 patients evaluated as D and 6 as E. In the 47
patients in whom lung biopsy was performed during the
Glenn procedure, age ranged from 19 days to 18 years
(mean, 3.7 years). Lung biopsy resulted in 5 patients rated
as A, 5 as B, 7 as C, 26 as D, and 4 as E. In the 6 patients in
whom lung biopsy was performed during re-PAB, 4 were
evaluated as D and 2 as E. The 3 patients who underwent
open lung biopsy after the Glenn procedure included 2
patients rated as C and 1 as D. The patient whose lung
biopsy specimen was obtained during the Fontan procedure
was evaluated as D, and the Fontan was subsequently taken
down due to insufficient postoperative pulmonary blood
flow.
Autopsy in cases of complex cardiac malformations
There were 10 autopsy cases associated with congenital
heart disease, including 4 HLHS (1, 4, 6, and 12 months
old), 4 SV (1, 5, and 21 months, and 15 years old), 1
DORV (11 months old), and 1 TGA (1 month old).
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TOF
There were 7 patients with TOF associated with pulmonary
hypertension whose ages ranged from 7 months to 37 years
(mean, 7 years). Shunt surgery was thought to be the cause
of pulmonary hypertension in all of these patients. They
were evaluated as follows: A in 2 patients, B in 3, C in 1,
and D in 1. In the 5 patients categorized as A or B, mild
intimal fibrous hypertrophy was observed and radical sur-
gery was indicated. On the other hand, the 2 patients cat-
egorized as C or D with proliferation of the longitudinal
muscle cells had previously undergone central shunt sur-
gery. Radical surgery was not indicated in 1 of 2 because of
severe occlusion of the longitudinal smooth muscle cells in
small pulmonary arteries.
IPPHN
There were 8 patients with IPPHN (5 days to 6 months old).
Of these, 4 were autopsy cases. No obstructive pulmonary
vascular lesions were identified and all were categorized as
HE I and IPVD 1.0. The patients had been treated with nitric
oxide or bosentan since birth, and histopathological exami-
nation revealed extensive hypoplasia in the respiratory sys-
tem and also in the small pulmonary arteries.
Acquired heart disease
The 60 patients with acquired heart disease included 16
with IPAH (3 autopsy cases), 36 with CTEPH, 6 with
PVOD (1 autopsy case), and 2 with acquired combined
valvular disease.
IPAH
Of the 16 patients clinically diagnosed with IPAH, 7 had a
juvenile type and 9 had an adult type, and ages ranged from
15 months to 54 years (mean, 20 years). The 3 autopsy
cases included a 27-year-old patient who died from scir-
rhous complications, a 10-year-old patient who died from
respiratory failure including atelectasis, and a 19-year-old
patient who died from complications of advanced
obstructive pulmonary vascular disease including angiitis.
In 4 patients with IPAH associated with ASD, lung biopsy
was performed to determine whether surgery was indi-
cated. These patients had a juvenile type (11 and
11 months, and 16 and 25 years), with progressive medial
hypertrophy more than 40 % in wall thickness. In 2
patients with IPVD 1.0, ASD closure deemed possible with
the use of vasodilators and 1 patient underwent surgery.
The other 2 patients had high IPVD (2.3 and 2.8) and thus
ASD closure was not performed in order to maintain a
safety valve for the right-to-left shunt.
Lung transplantation was performed on 9 patients,
ranging in age between 11 and 54 years. There were 8
cases of the adult type, where IPVD was between 2.7 and
3.2 (mean, 3.0) and advanced obstructive pulmonary vas-
cular lesions, including plexiform lesions, were observed.
CTEPH
In the 36 patients with CTEPH, intraoperative lung biopsy
was performed to evaluate both the effects of the endar-
terectomy and prospects for long-term postoperative qual-
ity of life as well as to provide patients with guidance
regarding daily life activities. Their ages ranged from 28 to
75 years (mean, 55 years). There were 30 patients with
New York Heart Association grade III and 6 with IV. The
mean pulmonary arterial pressure of each patient ranged
from 28 to 65 mmHg (overall mean, 46 mmHg). After lung
biopsy, 12 patients were evaluated as A, 10 as B, 6 as C,
and 8 as D. In all the patients rated D, the pulmonary artery
was occluded by many layers of aged thrombi. The old
emboli were not recanalized and the media in the periph-
eral small pulmonary arteries were atrophied. Of particular
note in all of 36 patients, proliferation of collagen fibers
was observed in all of the pulmonary veins, similar to
findings in PVOD. Some of the pulmonary veins were
more than 75 % occluded, suggesting that hemodynamics
would be affected.
PVOD
There were 5 patients with PVOD who underwent lung
biopsy (3 months to 6 years old). All of them had severe
pulmonary hypertension. The pulmonary veins were
occluded by collagen fibers. Severe mitral regurgitation
was found in an autopsy case of a 48-year-old patient.
Combined valvular heart disease
There were 2 patients with combined valvular heart disease
who underwent lung biopsy (53 and 54 years old). Both
were evaluated as B.
Discussion
Deciding whether radical surgery is indicated in patients
with congenital heart disease is not straightforward and
depends on the type of disease. Based on our past experi-
ence, we have been evaluating whether surgery is indicated
in patients with various congenital heart diseases based on
IPVD scores [2]. In patients with simple cardiac anomalies
such as VSD where the pulmonary arteries are directly
subjected to systemic arterial pressure, surgery is indicated
28 Gen Thorac Cardiovasc Surg (2013) 61:24–31
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when IPVD B 2.0 in patients without Down syndrome and
IPVD B 2.1 in patients with Down syndrome [5]. These
criteria were used in the present report; however, no dif-
ferences were found in the severity of obstructive pul-
monary vascular lesions between these two patient
populations, probably because the mean age was low
(23 months). Absolute operative contraindications were
observed as early as the age of 1 month in patients without
Down syndrome and 3 months in patients with Down
syndrome. This is why lung biopsy is important even in
patients as young as 1 month. In all patients, it was
expected that PAB would cause blocking and involution of
obstructive pulmonary vascular lesions. In particular, rad-
ical surgery was indicated 1 year after PAB in a 4-month-
old and 2 years after PAB in a 7-month-old; both did not
have Down syndrome, but had the finding of absolute
operative contraindication. They underwent surgery safely.
Of the 3 patients with extremely thickened media of
small pulmonary arteries where radical surgery was not
indicated, there was 1 patient where surgery was indicated
when he was re-biopsied 14 months after PAB; this patient
underwent radical surgery. This demonstrates that patients
with extremely thickened media of small pulmonary
arteries can become candidates for surgery after PAB.
All 12 patients with AVSD who were not deemed can-
didates for radical surgery had Down syndrome demon-
strating that it aggravates obstructive pulmonary vascular
lesions. Radical surgery was not indicated in 19 % of all
AVSD patients in the present report, which is approxi-
mately twice the 10 % rate of inoperable patients with
simple cardiac anomalies.
In most patients with AVSD as well as simple cardiac
anomalies, lung biopsy was performed during PAB. A two-
stage procedure helped prevent mortality due to obstructive
pulmonary vascular lesions, indicating that this procedure
was highly recommended [13].
There were 8 ASD patients with associated IPAH; sur-
gery was indicated in the 5 patients where ASD closure
was performed and pulmonary hypertension was improved
by medication postoperatively. In 1 patient with plexogenic
arteriopathy evaluated as E, IPVD was 3.1, and collateral
circulation, such as in plexiform lesions, was complete,
leading to a diagnosis of Eisenmenger syndrome. Since the
prognosis of Eisenmenger syndrome associated with ASD
is good even without treatment, this patient was followed
with observation.
Since the mean age of the 20 patients with TAPVC who
underwent radical surgery was 10.5 days, obstructive pul-
monary vascular lesions were not present. In cases where a
second surgery or autopsy was performed, IPVD was B1.6
and surgery was indicated in all cases since obstructive
pulmonary vascular lesions were under the operative
indication. However, in 7 patients who underwent an initial
surgery, there was significant hypoplasia of the small pul-
monary arteries. As we previously reported, hypoplasia of
small pulmonary arteries can result in death if patients do
not have sufficient pulmonary blood flow after surgery
[14]. Therefore, when an ASD is small (B3 mm) and
hypoplasia of the small pulmonary arteries is suspected in
patients with TAPVC, it is necessary to retain or enlarge
the ASD. If hypoplasia of the small pulmonary arteries
improves and sufficient pulmonary blood flow is main-
tained after surgery, then the ASD can be closed.
In 13 autopsy cases of TAPVC, the most common cause
of death was PVO (12 cases), indicating that postoperative
PVO is a serious issue. It had previously been reported that
lymphangiectasia was observed in 30 % of patients with
TAPVC [10], but in the present study a higher (40 %)
frequency of lymphangiectasia was observed.
The most common primary disease in Fontan candidates
was SV, but there were also many patients with DORV,
AVSD and TA where the Fontan procedure was deter-
mined to be the best treatment given the hypoplasia of the
left and right ventricles. In patients without PS, PAB must
be performed. In the present report, lung biopsy was per-
formed even during PAB in such patients, but biopsy was
not very useful because hypertrophy of the media was
advanced. Instead, lung biopsy performed during the Glenn
procedure was mainly used to determine whether the
Fontan procedure was indicated. Of the 47 patients where
lung biopsy was performed during the Glenn procedure, 30
were considered not to be candidates for the Fontan pro-
cedure. These 30 patients had high pulmonary arterial
pressure and pulmonary vascular resistance, and lung
biopsy was performed as the final decision of Fontan
operation. These patients are currently awaiting normali-
zation of hypertrophy of the media with medication.
In patients with TOF, a Blalock–Taussig (BT) shunt is
usually created. If sufficient pulmonary blood flow is not
obtained after this procedure, a central shunt may be created
to directly connect the right ventricle to the pulmonary trunk
using a more than 5-mm artificial graft. However, the
present study revealed that advanced hypertrophy of the
longitudinal smooth muscle cells can occlude the pulmonary
arteries and thus a central shunt should be avoided [15].
In IPPHN, hypoplasia of the respiratory system has been
pointed out and patients have been treated with high fre-
quency jet ventilation and extracorporeal membrane oxy-
genation. However, the prognosis remains extremely poor.
According to the findings in the present report, extensive
hypoplasia was observed also in the small pulmonary
arteries, suggesting that IPPHN can be treated with a BT
shunt to improve pulmonary blood flow.
Plexogenic arteriopathy was observed in all cases of
IPAH. In all patients who were candidates for lung trans-
plantation, collateral circulation, such as plexiform lesions,
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was complete and thus it was thought that lung transplan-
tation was the only treatment option.
In contrast, in the 2 juvenile type IPAH patients with
ASD, there were no advanced obstructive pulmonary vas-
cular lesions and hypertrophy of the media. It was thought
that in these patients, ASD closure could be achieved with
vasodilators. In patients with ASD, even those with
advanced obstructive pulmonary vascular lesions, ASD
could work as a safety valve for the right-to-left shunt,
suggesting that such patients could achieve long-term
survival.
In CTEPH, it is presumed that the presence of thrombi
and the severity of lesions may vary from site to site in the
lung. However, evaluating the degree of occlusion in the
small pulmonary arteries via lung biopsy was effective in
determining whether sufficient blood flow to the peripheral
arteries was maintained after endarterectomy.
Although PVOD is rarely seen in children, 5 cases of
PVOD were found in children younger than 6 years old.
Although all of them had advanced pulmonary hyperten-
sion, clinical examinations such as cardiac catheterization
could not determine the diagnosis of PVOD. Therefore,
lung biopsy was performed. In particular, neoplasia of the
collagen fibers in the small pulmonary veins occluding the
lumen was observed, causing advanced pulmonary venous
hypertension.
Conclusion
We examined lung biopsy and autopsy specimens in 445
patients with pulmonary vascular disease associated with
pulmonary hypertension, including 385 patients with con-
genital disease and 60 with acquired disease. Of the 385
congenital heart disease patients, lung biopsy was per-
formed in 354 to determine whether surgery was indicated.
Of the 60 acquired heart disease patients, there were 16
with IPAH. Lung biopsy was performed in 36 patients with
CTEPH during endarterectomy, which was effective in
evaluating the long-term postoperative quality of life. In
addition, there were 6 patients with PVOD and 2 with
combined valvular disease.
Although in this study, prospective data were collected
in patients with pulmonary hypertension, the cardiac sur-
geon, pediatric cardiologist and cardiologist who requested
lung biopsy and autopsy for diagnosis of pulmonary vas-
cular disease were gratified with the results. However, a
retrospective study which includes long-term postoperative
prognoses is needed in the near future.
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